Lomustine is a chemotherapy agent with five decades of use in treating lymphomas and central nervous system tumors such as glioblastoma, an aggressive and incurable brain cancer. Despite being an older, off-patent medication, lomustine became the center of a pricing controversy when a single manufacturer acquired its exclusive rights and drastically increased its cost by […]
